CHINAAMC Hang Seng Biotech ETF (HKG:3069)

Assets	2.47B
Expense Ratio	0.75%
PE Ratio	22.03
Dividend (ttm)	0.05
Dividend Yield	0.30%
Ex-Dividend Date	Dec 18, 2025
Payout Frequency	Annual
Payout Ratio	6.96%
1-Year Return	-3.60%

Volume	9,465,623
Open	16.70
Previous Close	16.61
Day's Range	16.43 - 16.80
52-Week Low	11.69
52-Week High	18.62
Beta	0.63
Holdings	10
Inception Date	Mar 18, 2021

About 3069

CHINAAMC Hang Seng Biotech ETF is headquartered in Beijing, China.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3069
• Provider: ChinaAMC
• Index Tracked: Hang Seng Biotech Index - HKD - Benchmark TR Net

Performance

3069 had a total return of -3.60% in the past year, including dividends. Since the fund's inception, the average annual return has been -6.55%.

Top Holdings

68.76% of assets

Name	Symbol	Weight
Innovent Biologics, Inc.	1801	10.03%
BeOne Medicines AG	6160	10.03%
WuXi Biologics (Cayman) Inc.	2269	9.78%
WuXi AppTec Co., Ltd.	2359	8.31%
Akeso, Inc.	9926	7.23%
CSPC Pharmaceutical Group Limited	1093	6.27%
Sino Biopharmaceutical Limited	1177	5.07%
Hansoh Pharmaceutical Group Company Limited	3692	5.00%
3SBio Inc.	1530	3.82%
Citigroup Global Markets Holdings Inc.	C.0 02.18.27 000A	3.21%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 18, 2025	0.050 HKD	Dec 31, 2025
Dec 18, 2024	0.060 HKD	Dec 31, 2024
Dec 18, 2023	0.030 HKD	Dec 29, 2023
Dec 19, 2022	0.040 HKD	Dec 30, 2022

Data Sources: S&P Global Market Intelligence, Twelve Data, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error